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Summary
Background: Human MST/hSAV/LATS/hMOB tumor suppres-
sor cascades are regulators of cell death and proliferation;
however, little is known about other functions of MST/hMOB
signaling. Mob1p, one of two MOB proteins in yeast, appears
to play a role in spindle pole body duplication (the equivalent
of mammalian centrosome duplication). We therefore investi-
gated the role of human MOB proteins in centrosome duplica-
tion. We also addressed the regulation of human centrosome
duplication by mammalian serine/threonine Ste20-like (MST)
kinases, considering that MOB proteins can function together
with Ste20-like kinases in eukaryotes.
Results: By studying the six human MOB proteins and five
MST kinases, we found that MST1/hMOB1 signaling controls
centrosome duplication. Overexpression of hMOB1 caused
centrosome overduplication, whereas RNAi depletion of
hMOB1 or MST1 impaired centriole duplication. Significantly,
we delineated an hMOB1/MST1/NDR1 signaling pathway
regulating centrosome duplication. More specifically, analysis
of shRNA-resistant hMOB1 and NDR1 mutants revealed that
a functional NDR/hMOB1 complex is critical for MST1 to phos-
phorylate NDR on the hydrophobic motif that in turn is required
for human centrosome duplication. Furthermore, shRNA-
resistant MST1 variants revealed that MST1 kinase activity is
crucial for centrosome duplication whereas MST1 binding to
the hSAV and RASSF1A tumor suppressor proteins is dispens-
able. Finally, by studying the PLK4/HsSAS-6/CP110 centriole
assembly machinery, we also observed that normal daughter
centriole formation depends on intact MST1/hMOB1/NDR
signaling, although HsSAS-6 centriolar localization is not
affected.
Conclusions: Our observations propose a novel pathway in
control of human centriole duplication after recruitment of
HsSAS-6 to centrioles.
Introduction
Centrosomes function as the main microtubule-organizing
centers in animal cells. Each centrosome is composed of
two centrioles surrounded by pericentriolar material [1–3].
They play an important part in organizing the bipolar spindle
during mitosis, ensuring equal distribution of genetic material
between the two daughter cells. Centrosomal components are
further required for the assembly and maintenance of cilia and
flagella, two structures with essential functions in mammalian
development and physiology [4, 5]. Therefore, the doubling of
centrosomes during S phase (termed centrosome duplication)
*Correspondence: hergo@fmi.chis under strict control. Studies with mammalian cells have
shown that centriole duplication is orchestrated by different
protein kinases, such as polo-like kinase 4 (PLK4), cyclin-
dependent kinase 2 (Cdk2), and NDR kinases [6–9].
The NDR/LATS family is a subgroup of AGC serine/threonine
protein kinases and consists of four related kinases (NDR1/
STK38, NDR2/STK38L, LATS1, and LATS2) in the mammalian
genome [10]. Although members of the NDR family have
been detected on spindle pole bodies (SPB) and centrosomes,
only human NDR1/2 kinases have been attributed a role in
centrosome duplication [11]. Although LATS1/2 kinases are
found on centrosomes, they are not involved directly in the
regulation of centrosome duplication in human cells [9]. In
multicellular organisms, LATS kinases play a central role in
Hippo/SWH (Salvador/Warts/Hippo) signaling, which coordi-
nates cell proliferation and apoptosis [12–14]. Initially delin-
eated in flies as the Hpo/Sav/Lats/dMOB1/Yki network,
mammalian MST/hSAV/LATS/hMOB/YAP tumor suppressor
signaling was also defined recently [15]. In mammalian cells,
this machinery regulates tissue homeostasis by balancing
cell proliferation and apoptotic events, where hSAV, MST1/2,
LATS1/2, and hMOB1 form complexes (summarized in [11]).
However, very little is known about other molecular functions
of MST/hMOB signaling.
Intriguingly, one study has already suggested that Mob1p
(the yeast counterpart of human hMOB1A/B proteins) plays
a role in SPB duplication [16]. Therefore, we analyzed in this
study all six human MOB proteins (hMOBs: hMOB1A,
hMOB1B, hMOB2, hMOB3A, hMOB3B, and hMOB3C) for a
potential involvement in centrosome duplication. Given that
MOB proteins can function together with Ste20-like kinases
in yeast, fly, and human cells [10], we further expanded our
study by addressing all human mammalian serine/threonine
Ste20-like kinases (MSTs: MST1, MST2, MST3, MST4, and
SOK1) in centrosome duplication. Significantly, we found that
MST1/hMOB1 signaling is required for centrosome duplica-
tion. Furthermore, we show here that centriole formation
depends on intact MST1/hMOB1/NDR signaling, although
the association of HsSAS-6 with centrioles appears to be
normal.
Results
Overexpression of hMOB1A/B Results in Centrosome
Overduplication
Given the intriguing observation with Mob1p [16], we initially
addressed hMOBs in human centrosome duplication by over-
expression studies (Figure 1). All six human MOB proteins
were overexpressed and the numbers of centrosomes per
mononucleated cell were determined by immunofluorescence
microscopy (Figure 1A). Except for hMOB2, all hMOBs were
detected mainly in the cytoplasm (Figure 1A). Overexpression
of hMOB1A/B caused a significant increase in cells displaying
extra centrosomes (three or more centrosomes per cell),
whereas expression of hMOB2, hMOB3A, and hMOB3B had
no effect (Figure 1B). Overexpression of hMOB3C resulted in
slightly increased centrosome amplification in U2-OS cells
(Figure 1B) but did not cause centrosome amplification in
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(A and C) U2-OS expressing indicated human MOB proteins (1A, 1B, 2, 3A, 3B, or 3C) for 48 hr were processed for immunofluorescence (A) or immunoblot-
ting (C) with the indicated antibodies.
(A) Insets show enlargements of centrosomes in green. DNA is stained blue.
(B) Histograms showing percentages of cells with excess centrosomes (more than three per mononucleated cell;R3). Cumulative data from two indepen-
dent experiments with at least two replicates of 100 cells counted per experiment. Error bars indicate standard deviations.
(D) Histograms showing percentages of cells with supernumerary centrosomes in HeLa cells. Cells were incubated with aphidicolin (2 mg/ml) for 8 hr before
being transfected with indicated cDNAs. Cells were incubated for a further 48 hr before processing for immunofluorescence. Cumulative data from two
independent experiments with at least two replicates of 100 cells counted per experiment. Error bars indicate standard deviations.
(E) Staining of U2-OS cells expressing HA-hMOB1A(wt) with antibodies against Cep170 (green), centrin (red), and HA (blue). Enlargements of centrioles
are shown.
(F) Quantification analysis of the experiment shown in (E). Cumulative data from three independent experiments with at least 100 cells counted per
experiment. Error bars indicate standard deviations.HeLa cells (Figure 1D). Notably, of the six hMOBs, expression
levels of hMOB1A and hMOB1B were consistently the lowest
for unknown reasons (Figure 1C; data not shown).
To investigate whether the generation of supernumerary
centrosomes resulting from hMOB1A/B overexpression is
a consequence of centriole/centrosome overduplication or
failure of cytokinesis, we arrested HeLa cells in S phase by
aphidicolin treatment and compared the induction of centro-
some amplification to that in untreated normally cyclingcells. Significantly, hMOB1A/B overexpression triggered
centrosome amplification regardless of the presence or
absence of aphidicolin (Figure 1D; data not shown). Centro-
somes do not overduplicate spontaneously during prolonged
S phase arrest in HeLa [17, 18], so these data suggest that
hMOB1A/B overexpression causes centrosome amplification
by an overduplication mechanism. To verify this finding, we
analyzed hMOB1A-overexpressing cells with increased
centrosome number for Cep170 staining (Figure 1E). If
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the majority of cells should contain only one Cep170-positive
centriole, whereas failure of cell division would cause the
accumulation of at least two mature Cep170-positive centri-
oles [19]. As seen in Figures 1E and 1F, the majority of
hMOB1A-expressing cells with supernumerary centrioles dis-
played only one Cep170-positive centriole, suggesting that
hMOB1A/B overexpression causes centrosome overduplica-
tion in our experimental system.
Endogenous hMOB1A/B Is Required for Centrosome
(Over)duplication
To study endogenous hMOB1A/B, centrosome overduplica-
tion assays [20] were performed in U2-OS cells depleted of
hMOB1A/B (Figure 2). In parallel to the generation of a
hMOB1A/B antibody that selectively recognized hMOB1A
and hMOB1B (Figure S1 available online), stable cell lines
were generated expressing tetracycline-inducible short hairpin
RNA (shRNA) directed against hMOB1A/B (Figure 2A). Of note,
hMOB1A and hMOB1B mRNAs had to be targeted simulta-
neously by two different shRNAs, to allow efficient knockdown
of total hMOB1A/B protein levels (Figure 2A). Significantly,
centrosome amplification was altered in hMOB1A/B-depleted
cells upon S phase arrest (Figures 2B and 2C). To ensure the
specificity of our RNAi experiments, wild-type hMOB1A cDNAs
refractory to shRNA were introduced into U2-OS cells express-
ing inducible vector-based RNAi (Figure 2D). Expression of
shRNA-resistant hMOB1A restored centrosome overduplica-
tion upon depletion of endogenous hMOB1A/B (Figure 2E),
indicating that the failure of hMOB1A/B-depleted cells to
efficiently overduplicate centrosomes is due to specific
knockdown of endogenous hMOB1A/B.
To address hMOB1A/B in normal centriole duplication, we
analyzed centriole numbers at the end of the centriole duplica-
tion cycle [9, 21]. Nearly 50% of hMOB1A/B-depleted cells
lacked at least one centriole in early mitotic stages (Figures
2F and 2G; control: 9.3% 6 1.7%; hMOB1A/B knockdown:
47.2% 6 8.7%). About 34% of hMOB1A/B-depleted cells
displayed bipolar spindles containing only three centrioles
instead of the normal four centrioles per cell (untreated control
background: 8%), and 13% of hMOB1A/B-depleted cells con-
tained only one or two centrioles (control: 2%). Depletion of
endogenous hMOB1A/B in HeLa and diploid untransformed
RPE1 cells also resulted in decreased centriole numbers
(Figure S2). U2-OS cells expressing shRNA-resistant hMOB1A
did not display a significant loss of centrioles upon depletion of
endogenous hMOB1A/B (Figure 2G; control: 10.2% 6 2.9%;
hMOB1A/B knockdown with shRNA-resistant hMOB1A:
13.5% 6 4%), suggesting that endogenous hMOB1A/B
contributes to normal centriole duplication in human cells.
hMOB1A/B Regulates Hydrophobic Motif Phosphorylation
of NDR Kinase
hMOB1A/B proteins have already been reported to interact
with NDR kinases [22–27]; hence, NDR1/2 protein levels were
analyzed in hMOB1A/B-depleted cells upon S phase arrest.
Significantly, phosphorylation of NDR1/2 on Thr444 (the
hydrophobic motif of NDR1) was strongly diminished upon
hMOB1A/B knockdown (Figure 2A) and partially restored by
expression of shRNA-resistant hMOB1A (Figure 2D). This
finding was surprising, because recombinant hMOB1A did
not cause an increase in NDR1/2 phosphorylation on Thr444
in vitro [22] and hMOB1A/B is not required for hydrophobic
motif phosphorylation of LATS1 in cells [26]. Nevertheless,our findings suggest that hMOB1A/B regulates the phosphor-
ylation of NDR1/2 on Thr444 by upstream kinase(s) upon S
phase arrest of cells.
hMOB1/NDR Complex Formation Is Essential for Efficient
Centrosome Duplication and NDR Phosphorylation
Before addressing the nature of the upstream kinase(s), we
determined whether the interaction of hMOB1A/B with NDR1/
2 is required for the regulation of centrosome duplication. First,
the effects of selected NDR1 mutants (initially defined in
[22, 25]) on the centrosome cycle were examined (Figure 3).
These NDR1 mutants displayed intact hMOB2 binding,
although interactions with hMOB1A/B (also termed hMOB1)
were undetectable (Figure S3; data not shown). All NDR1 vari-
ants expressed at comparable levels and displayed similar
subcellular distribution (Figures 3A and 3B; data not shown).
However, only overexpression of NDR1(wt) resulted in centro-
some amplification (Figure 3C). Overexpression of NDR1
kinase-dead (kd) or NDR1 deficient in hMOB1 binding did not
increase centrosome numbers (Figure 3C). Expression of
shRNA-resistant NDR1 mutants did not restore centrosome
overduplication upon depletion of endogenous NDR1 (Fig-
ure 3E). These mutants also displayed dramatically decreased
phosphorylation on Thr444 (Figure 3D), suggesting that NDR1/
hMOB1 complex formation is required for Thr444 phosphoryla-
tion and centrosome amplification.
To further address the role of hMOB1/NDR complex forma-
tion, we generated a hMOB1A(E51K) mutant deficient in
NDR1/2 binding (Figure S4). Overexpression of hMOB1A(E51K)
did not lead to centrosome overduplication, even though
expression and localization were not significantly changed
(Figure S5). Moreover, shRNA-resistant hMOB1(E51K) did not
compensate for the depletion of endogenous hMOB1A/B (Fig-
ure S5). Furthermore, although NDR1 expression and subcel-
lular localization were not obviously affected upon knockdown
of hMOB1A/B, NDR1-driven centrosome overduplication was
impaired in hMOB1A/B-depleted cells (Figure S6; data not
shown). Inversely, centrosome amplification resulting from
overexpression of hMOB1A was decreased in NDR1-depleted
cells (Figure S6; data not shown). Overall, the findings
described in Figure 3 and Figures S5 and S6 strongly suggest
that a functional hMOB1/NDR complex is indispensable for
centrosome overduplication.
MST1Kinase Regulates Centrosome (Over)duplication and
NDR Phosphorylation in a hMOB1A/B-Dependent Manner
Our data shown in Figure 2 and Figure S5 suggested that
hMOB1A/B regulates the phosphorylation of NDR1/2 by
upstream kinase(s). Therefore, we investigated whether any
of the postulated upstream activators (the entire group of
MST kinases [10]) is responsible for Thr444 phosphorylation
in a hMOB1A/B-dependent manner (Figure 4). In U2-OS cells,
overexpression of MST1(wt) increased phosphorylation of
endogenous NDR1/2 the most efficient (Figure 4A and
Figure S7), although MST1, MST2, and MST3 can phosphory-
late NDR1/2 on Thr444 in vitro [27, 28]. This increase in
NDR1/2 phosphorylation was dependent on MST1 kinase
activity (Figure 4A) and was blocked in hMOB1A/B-depleted
cells but restored by expression of shRNA-resistant
hMOB1A(wt) upon hMOB1A/B knockdown (Figure 4B). In full
agreement with our previous observations (Figure 2 and
Figure S5) these results suggest that MST1 phosphorylates
NDR1/2 on Thr444 in a hMOB1A/B-dependent manner.
Furthermore, they suggest that MST1 kinase might be involved
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(A and B) U2-OS cells stably expressing tetracycline-regulated short-hairpin RNA (shRNA) directed against hMOB1A/B were incubated for 72 hr without (2)
or with (+) tetracycline (2 mg/ml) and for a further 72 hr with aphidicolin (2 mg/ml), before processing for immunoblotting (A) or immunofluorescence (B) with
the indicated antibodies.
(B) DNA is in blue. Insets show centrosome enlargements in red.
(C) Histograms showing percentages of cells with excess centrosomes (R3) incubated without (2) or with (+) tetracycline, followed by incubation with aphi-
dicolin. Cumulative data from three independent experiments with at least two replicates of 100 cells counted per experiment. Error bars indicate standard
deviations.
(D) U2-OS stably expressing shRNA against hMOB1A/B were infected with empty vector (lanes 1–4) or HA-hMOB1A wild-type cDNA (lanes 5–8) that is
refractory to shRNA [wt_9N]. After incubation for 72 hr with (+) or without (2) tetracycline and for an additional 72 hr with aphidicolin, cells were processed
for immunoblotting with the indicated antibodies.
(E) In parallel, cells were processed for immunofluorescence to determine centrosome numbers per cell. Histograms show the percentage of cells with
excess centrosomes (R3) incubated without (2) or with (+) tetracycline, followed by incubation with aphidicolin. Cumulative data from two independent
experiments with at least two replicates of 100 cells counted per experiment. Error bars indicate standard deviations.
(F) U2-OS cells expressing shRNA directed against hMOB1A/B were incubated without (2) or with (+) tetracycline for 96 hr, before processing for immuno-
fluorescence with centrin (green) and a-tubulin (red) antibodies. DNA is shown blue.
(G) Histograms showing percentages of mitotic cells in prophase and prometaphase that displayed the loss of at least one centriole (%3 centrioles per cell)
in the presence (+) or absence (2) of tetracycline. Cumulative data from three independent experiments with at least 100 cells counted per experiment. Error
bars indicate standard deviations.
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(A and B) U2-OS cells expressing HA-NDR1 wild-type(wt), kinase-dead(kd), or hMOB1A/B binding mutants (Y31A, R41A, or T74A) for 48 hr were processed
for immunoblotting (A) or immunofluorescence (B) with the indicated antibodies.
(B) Insets show enlargements of centrosomes in green. DNA is stained blue.
(C) Histograms showing percentages of cells with excess centrosomes (R3). Cumulative data from three independent experiments, with at least 150 cells
counted per experiment. Error bars indicate standard deviations.
(D and E) U2-OS cells stably expressing tetracycline-regulated short-hairpin (shRNA) directed against human NDR1 were infected with empty vector (lanes
1–3), HA-NDR1 wild-type (lanes 4 and 5), or hMOB1A/B binding mutants (lanes 6–11) that are refractory to shRNA [HA-NDR1(6N)]. After incubation for 72 hr
without (2) or with (+) tetracycline and for a further 72 hr with aphidicolin, cells were analyzed by immunoblotting with the indicated antibodies (D) or by
immunofluorescence for centrosome numbers (E).
(E) Histograms showing percentages of cells with excess centrosomes (R3). Cumulative data from two independent experiments, with at least two
replicates of 100 cells counted per experiment. Error bars indicate standard deviations.in the regulation of centrosome (over)duplication and Thr444
phosphorylation upon S phase arrest.
To address this experimentally, stable cell lines were
generated expressing tetracycline-inducible shRNA directed
against MST1 (Figure 4C). Phosphorylation of NDR1/2 onThr444 was decreased in MST1-depleted cells (Figure 4C), indi-
cating that MST1 is the main upstream kinase under these
conditions. Significantly, centrosome overduplication was
decreased upon MST1 knockdown (Figure 4D). By analyzing
the number of centrioles at the end of the centriole duplication
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(A) U2-OS transfected with indicated cDNAs for 20 hr were processed for immunoblotting with the indicated antibodies.
(B) U2-OS stably expressing shRNA against hMOB1A/B (lanes 1–3), or the same cells infected with empty vector (lanes 4–6) or shRNA-resistant HA-hMOB1A
(wt_9N) (lanes 7–9) were incubated without (2) or with (+) tetracycline for 72 hr before being transfected with HA-MST1(wt) overnight. Subsequently, cells
were processed for immunoblotting with the indicated antibodies.
(C) U2-OS cells stably expressing tetracycline-regulated short-hairpin RNA (shRNA) directed against human MST1 were incubated for 72 hr without (2) or
with (+) tetracycline and for a further 72 hr with aphidicolin, before processing for immunoblotting.
(D) In parallel, cells were analyzed by immunofluorescence microscopy. Histograms show the percentages of cells with excess centrosomes (R3) incubated
without (2) or with (+) tetracycline, followed by incubation with aphidicolin. Cumulative data from three independent experiments with at least two replicates
of 100 cells counted per experiment. Error bars indicate standard deviations.
(E) U2-OS stably expressing shRNA against MST1 were analyzed after 96 hr with (+) or without (2) tetracycline. Histograms show the percentage of mitotic
cells in prophase and prometaphase that lost at least one centriole (%3 centrioles per cell). Cumulative data from three independent experiments with at
least 100 cells counted per experiment. Error bars indicate standard deviations.
(F and G) U2-OS cells expressing the indicated cDNAs were processed for immunoblotting (F) or immunofluorescence (G) with indicated antibodies.
(G) Insets show centrosome enlargements in green. DNA is shown blue.
(H) Histograms showing percentages of cells with excess centrosomes (R3). Cells expressing the indicated kinase-dead(kd) MST kinases were incubated
with aphidicolin for 72 hr. Cumulative data from four independent experiments with at least two replicates of 100 cells counted per experiment. Error bars
indicate standard deviations.cycle (see Figure 2F), we found that 32%of MST1-depleted cells
lacked at least one centriole (Figure 4E; control: 10.1%6 0.7%;
MST1 knockdown: 32.3%6 4.5%). Knockdown of endogenousMST1 in HeLa and RPE1 cells also caused loss of centrioles
(Figure S2), indicating that endogenous MST1 contributes to
normal centriole duplication in different human cells.
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(kd) overexpression (Figures 4F–4H), because MST1(kd) can
function as a dominant-negative kinase [29]. Significantly,
centrosome overduplication was impaired in U2-OS cells ex-
pressing MST1(kd), whereas overexpression of MST2(kd),
MST3(kd), MST4(kd), or YSK1/SOK1(kd) had no effect, despite
similar expression and subcellular localization patterns (Fig-
ures 4F–4H; data not shown). Because MST2(kd), MST3(kd),
MST4(kd), and SOK1(kd) can also function as dominant-nega-
tive kinases [30], these findings suggest that mainly MST1
contributes to centrosome overduplication in our settings.
However, although MST1 plays a role in NDR1/2 phosphoryla-
tion and centrosome duplication (Figure 4), these findings did
not necessarily demonstrate that NDR-driven centrosome
duplication requires MST1. Thus, we determined the effect of
NDR1(wt) or hMOB1A overexpression on centrosome amplifi-
cation in MST1-depeleted cells, revealing that NDR1- or
hMOB1A-driven centrosome overduplication was impaired in
MST1-depleted cells (Figure S8). Therefore, it is very likely
that centrosome duplication is regulated by MST1/hMOB1/
NDR signaling in our experimental systems.
MST1 Kinase Activity, but Not RASSF1A or hSAV Binding,
Is Required for Centrosome Amplification
MST1 kinase is controlled by various mechanisms [30], most
importantly by binding to RASSF1A, hSAV, or to itself via a
C-terminally located SARAH (Sav/Rassf/Hippo) domain [31–
35]. Therefore, we generated a C-terminally truncated form of
MST1 (residues spanning 1–433; termedDC) that was deficient
in hSAV-, RASSF1A-, and homodimer-complex formation
(Figure S9). Surprisingly, overexpressed MST1(DC) phosphor-
ylated NDR1/2 on Thr444 similarly to MST1(wt) kinase
(Figure S9).
Given this observation, we introduced MST1(wt), (kd), and
(DC) cDNAs refractory to shRNA into U2-OS-expressing induc-
ible vector-based RNAi against MST1 (Figure 5A). Although
expression of shRNA-resistant MST1(wt) restored centrosome
overduplication and Thr444 phosphorylation of NDR1/2 in
MST1-depleted cells, shRNA-resistant MST1(kd) did not
compensate for MST1 depletion, despite similar localization
and expression levels (Figure 5; data not shown). Significantly,
expression of shRNA-resistant MST1(DC) supported centro-
some amplification upon depletion of endogenous MST1
(Figure 5B) and phosphorylation of Thr444 (Figure 5A). These
data show that binding of MST1 to RASSF1A, hSAV, or homo-
dimer formation through the SARAH domain is dispensable for
centrosome overduplication, whereas MST1 kinase activity is
crucial.
The MST1/hMOB1/NDR Cascade Is Required for Human
Centriole Duplication, but Dispensable for Centriolar
‘‘Seed’’ Formation
To understand in more detail the role of MST1/hMOB1/NDR
signaling in human centriole duplication, we investigated
whether the MST1/hMOB1/NDR machinery is required for
PLK4-driven centriole biogenesis (Figure 6). As already
reported [21], overexpression of PLK4 is sufficient to trigger
centriole amplification, where two types of procentriole
arrangements have been observed: centrioles arranged either
in (1) flower-like structures around parental centrioles, or (2)
clusters of centrioles after disengagement [36]. Significantly,
PLK4-driven centriole amplification was impaired in
hMOB1A/B-, MST1-, or NDR1-depleted cells, although PLK4
expression and centriole localization were not obviouslyaffected (Figure 6; Figure S10; data not shown). Moreover, no
significant differences in cell cycle profiles were observed
upon depletion of MST1/hMOB1/NDR signaling components
and/or PLK4 overexpression (Figure 6D; Figures S10 and
S11), suggesting that the observed defect in centriole amplifi-
cation is not simply a consequence of a general cell cycle
arrest. Overall, reduction of MST1/hMOB1/NDR signaling
appears to negatively affect PLK4-driven centriole biogenesis
without any direct effect on PLK4 expression, subcellular local-
ization, and cell cycle profiles.
Next, we addressed whether MST1/hMOB1/NDR signaling
might play a role in other steps of the centriole assembly
pathway conserved from lower to higher eukaryotes [37–52].
In human cells, after the activation of PLK4 on the parental
centriole, g-tubulin, CPAP, Cep135, and HsSAS-6 are rapidly
recruited to the centriole [36]. Then, CP110 forms a cap on
the newly forming procentriole, and finally, the centriole grows
by addition of tubulin. To determine any involvement of MST1/
hMOB1/NDR signaling in this pathway, we focused our anal-
ysis on centrosomes and centrioles at the end of the centriole
duplication cycle (as already defined in Figure 2F). Cell lines
expressing inducible shRNA directed against hMOB1A/B,
MST1, or NDR1 were cultured in the absence or presence of
tetracycline without apparent changes in cell cycle profiles
and protein expression, except for the targeted proteins of
interest (Figures 7A and 7B; Figures S11 and S12). As expected
[53, 54], normal prophase cells (with condensed DNA and
Figure 5. MST1 Kinase Activity, Not the SARAH Domain, Is Required for
Centrosome Overduplication in Human Cells
(A) U2-OS stably expressing shRNA against MST1 were infected with empty
vector (lanes 1–3), HA-MST1 wild-type (lanes 4–6), kinase-dead (lanes 7–9),
or a C-terminally truncated mutant cDNA (DC; lanes 10–12) that is refractory
to shRNA [wt_7N, kd_7N, or DC_7N]. After incubation for 72 hr with (+) or
without (2) tetracycline and for an additional 72 hr with aphidicolin, cells
were processed for immunoblotting with indicated antibodies.
(B) In parallel, the number of centrosomes per cell was determined. Histo-
grams show the percentage of cells with excess centrosomes. Cumulative
data from three independent experiments with at least two replicates of
100 cells counted per experiment. Error bars indicate standard deviations.
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two CP110 signals at each spindle pole (Figures 7C and 7E).
Interestingly, the association of HsSAS-6 with prophase
centrosomes was not altered upon hMOB1A/B, MST1, or
NDR1 depletion (Figure 7C; data not shown). Irrespective of
the decreased centriole number per spindle pole, HsSAS-6
associated with centriole pairs or single centrioles (Figure 7D;
data not shown).
Next, to address in more detail whether the cell cycle-
dependent centriole localization of HsSAS-6 [54] relies on
MST1/hMOB1/NDR signaling components, we determined
the cell cycle stages of individual cells by PCNA staining (Fig-
ures S13 and S14). In full agreement with existing literature
[54], HsSAS-6 was not detected on centrioles in most U2-OS
cells during G1 phase, but was present on the majority of
centrioles in S and G2 phase (Figure S14). It is noteworthy
that depletion of hMOB1A/B, MST1, or NDR1 did not affect
this cell cycle-regulated HsSAS-6 localization pattern (Fig-
ure S14; data not shown). Taken together, these findings
suggest that the initiation of procentriole formation (also
termed centriolar ‘‘seed’’ formation; see [36, 54]) is indepen-
dent of MST1/hMOB1/NDR signaling.
In contrast, despite unaffected DNA condensation and
centrosome separation, a significant portion of hMOB1A/B-,
MST1-, or NDR1-depleted cells lacked at least one CP110
centriole signal in prophase (Figure 7E; control [without
Figure 6. PLK4-driven centriole biogenesis is
impaired upon hMOB1A/B or MST1 depletion
(A and B) U2-OS stably expressing shRNA
against hMOB1A/B (lanes 1–3), or MST1 (lanes
4–6) were incubated without (2) or with (+) tetra-
cycline for 72 hr before being transfected with
GFP-PLK4(wt) overnight. Subsequently, cells
were processed for immunoblotting (A) or immu-
nofluorescence (B) with the indicated antibodies.
(B) Insets show enlargements of centrioles. GFP-
PLK4 is in green and centrioles are shown in red.
DNA is stained blue.
(C) Histograms showing percentages of cells with
excess centrioles (R5). Cumulative data from
two independent experiments, with at least two
replicates of 100 cells counted per experiment.
Error bars indicate standard deviations.
(D) In parallel, cells from the same samples were
analyzed for DNA content by FACS.
tetracycline induction], 8% [n = 130];
hMOB1A/B knockdown, 44% [n = 142];
control, 7% [n = 121]; MST1 knockdown,
30% [n = 127]; control, 9% [n = 131];
NDR1 knockdown, 41% [n = 116]). As
already described for centrin-2 (see
Figures 2F, 2G, and 4E), CP110 signals
displayed reduced numbers of centri-
oles in depleted cells (Figure 7F; data
not shown). Two additional centriole
markers (glutamylated-tubulin and
acetylated-a-tubulin) further confirmed
that centriole numbers are decreased
upon hMOB1A/B, MST1, or NDR1
depletion (Figure S15; data not shown).
Overall, the analysis of depleted
cells with five independent centriole
markers—HsSAS-6, CP110, centrin-2,
glutamylated-tubulin, and acetylated-a-tubulin—revealed
that MST1/hMOB1/NDR signaling is required for normal
centriole duplication in human cells, although the association
of HsSAS-6 with centrioles does not appear to be affected.
Discussion
Taken together, our findings indicate that MST1/hMOB1/NDR
signaling contributes to centriole duplication in human cells.
Endogenous hMOB1A/B and MST1 are required for normal
centriole duplication (Figures 2, 4, and 5). The association of
hMOB1A/B with NDR1/2 kinases is essential for centrosome
duplication (Figure 3; Figure S5). Moreover, centrosome over-
duplication requires MST1 kinase activity but is independent
of the SARAH domain of MST1 (Figure 5). Because MST1
binding to hSAV, RASSF1A, NORE1, and CNK1 depends on
the SARAH domain of MST1 [30], this suggests that all
currently known activators/inhibitors of MST1 are unlikely to
contribute to MST1 signaling in centrosome duplication.
Our data would indicate that MST1 kinase activity plays
a role in human centrosome duplication, although MST1 is
best known as a proapoptotic kinase [30] whose activity is
enhanced by RASSF1A/MST1 complex formation [34].
RASSF1A binding to MST1 through the SARAH domain also
increased NDR1/2 kinase activity in apoptotic cells [27]. In
contrast, MST1 signaling in centrosome duplication is SARAH
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domain of MST1 might exemplify the means by which human
cells utilize similar signaling systems for the regulation of
very different biological processes (e.g., programmed cell
death versus centrosome duplication in the case of MST1/
hMOB1/NDR signaling). Considering further that centrosome
duplication occurs in S phase, it is tempting to speculate
that MST1 kinase regulates NDR1/2 kinases in a cell cycle-
dependent manner. Intriguingly, we could confirm the reported
[55] S-phase-induced phosphorylation of MST1 (Figure S16),
suggesting that MST1 kinase activity could oscillate during
the cell cycle. As a result, a new line of research will be required
to elucidate how MST1 activity is regulated (in)dependently of
its SARAH domain during the cell cycle. Hence, future research
addressing the role of MST1/hMOB1/NDR signaling in cell
cycle progression is warranted.
Our data suggest that MST1 regulates human centrosome
duplication through the phosphorylation of endogenous
NDR1/2 in S phase (Figures 4 and 5). However, human
LATS1/2, histone 2B (H2B), and FoxO have also been identified
as MST1 substrates [56–58]. In this context, it is noteworthy
that LATS1/2 are not involved in centrosome duplication [9].
Of further importance, caspase-cleaved MST1 phosphorylates
H2B in the nucleus, whereas full-length MST1 targets cytosolic
Figure 7. Centriole Localization of CP110, but
Not of HsSAS-6, Depends on MST1/hMOB1
Signaling
(A and B) U2-OS cells expressing shRNA directed
against hMOB1A/B (lanes 1 and 2) or MST1 (lanes
3 and 4) were incubated without (2) or with (+)
tetracycline for 96 hr before processing for
immunoblotting (A) or DNA content analysis by
FACS (B).
(C–F) In parallel, U2-OS cells expressing shRNA
directed against hMOB1A/B were processed for
immunofluorescence with indicated antibodies.
g-tubulin (centrosome) and acetylated-a-tubulin
(centriole) stainings are in red. DNA is shown
blue. Insets show enlargements of centro-
somes/centrioles. Schemes on the right indicate
HsSAS-6 and CP110 localization on centrioles
in green.
FoxO1 in a SARAH domain-dependent
manner [59]. Therefore, considering
that cytoplasmic MST1 lacking the
SARAH domain is capable of driving
centrosome overduplication (Figure 5;
data not shown), it is rather unlikely
that the phosphorylation of H2B or
FoxO by MST1 plays a role in the centro-
some cycle. Taking into further account
that shRNA-resistant NDR1(T444A)
cannot restore centrosome overduplica-
tion in NDR1-depleted cells (Figure S17),
our data indicate that the phosphoryla-
tion of NDR1/2 on Thr444 by MST1 is
a key event in the regulation of centro-
some duplication in this setting.
We also found that hydrophobic motif
phosphorylation of NDR1/2 requires
endogenous hMOB1A/B in addition to
MST1 (Figures 2 and 4). The analysis of
NDR1 and hMOB1A mutants (Figure 3;
Figure S5) showed that a functional NDR/hMOB1 complex is
critical for the phosphorylation of NDR on the hydrophobic
motif by MST1, which in turn is required for human centrosome
duplication (Figure S18).
Significantly, we also addressed at which step MST1/
hMOB1/NDR signaling controls centriole duplication in human
cells. Although PLK4-driven centriole amplification is impaired
upon depletion of MST1/hMOB1/NDR components, the asso-
ciation of PLK4 with centrioles is not affected (Figure 6). The
recruitment of HsSAS-6 to centrioles is also independent of
the MST1/hMOB1/NDR cascade (Figure 7). Therefore, the
two first steps of the human centriole assembly pathway [36,
54], namely PLK4 and HsSAS-6 localization to centrioles,
appear to be normal upon knockdown of MST1/hMOB1/NDR
signaling components. However, recruitment of centrin-2
and CP110 to procentrioles appears to depend on an intact
MST1/hMOB1/NDR cascade (Figures 2, 4, and 7). Although
the incorporation of CP110 and centrin-2 into nascent procen-
trioles occurs rapidly [36], we observed that a significant
fraction of MST1/hMOB1/NDR knockdown cells displayed
reduced centriole staining (Figures 2, 4, and 7). Collectively,
these observations suggest that MST1/hMOB1/NDR signaling
is important for efficient centriole duplication (daughter
centriole formation), even though the initiation of procentriole
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centrioles) appears to be normal (Figure S18).
The stabilization of a first centriolar seed is very likely to be
a rate-limiting step in human centriole duplication [36, 54].
However, our data would suggest that human centriole dupli-
cation can also be regulated after the initiation step involving
PLK4/HsSAS-6. Currently, we do not know precisely at which
step centriole duplication is blocked in MST1-, hMOB1-, or
NDR1-depleted cells (Figure S18). Most likely, a combination
of live cell imaging and electron microscopy will be required
to decipher exactly at which stage daughter centriole forma-
tion depends on MST1/hMOB1/NDR signaling. Given that the
MST1/hMOB1/NDR cascade also plays a role in the regulation
of apoptosis [27], future research will also be needed to
address how MST1/hMOB1/NDR signaling can be fine-tuned
to allow the regulation of different biological aspects by the
same signaling modules. In this context, another future chal-
lenge will be the identification of NDR substrates that play
a direct role in centriole duplication and/or apoptosis. A further
challenge will be to test how far the role of MST1/hMOB1/NDR
signaling in centrosome duplication is conserved from yeast to
man. Taken together, the elucidation of a role for the MST1/
hMOB1/NDR pathway in centrosome duplication reported
here might open novel avenues in the pursuit of centriole dupli-
cation signaling as well as molecular function(s) that might
contribute to tumor-suppressing activities of MST1 and
hMOB1.
Experimental Procedures
Cell Culture, Transfections, and Chemicals
U2-OS, HeLa, PT67, COS-7, and RPE1-hTert cells were maintained in
DMEM supplemented with 10% fetal calf serum. U2-OS, HeLa, COS-7,
and RPE1-hTert cells were plated at a consistent confluence and trans-
fected with Fugene 6 (Roche), jetPEI (PolyPlus Transfection), or Lipofect-
amine 2000 (Invitrogen) as described by the manufacturer. Aphidicolin
was from Calbiochem.
Generation of Stable Cell Lines
To generate tetracycline-inducible cell lines, U2-OS T-Rex cells were trans-
fected with pTER constructs [60] expressing shRNA against hMOB1A/B or
MST1. Cell clones were selected and maintained as described previously
[9]. Retroviral pools of rescue cell lines were generated as described else-
where [9]. U2-OS Tet-On cells expressing tetracycline-regulated shRNA
against NDR1 have been described already [9].
Immunoblotting, Immunoprecipitation, Cell Fractionation,
Immunofluorescence Microscopy, and FACS
Immunoblotting, coimmunoprecipitation, and cell fractionation experi-
ments were performed as described [25]. Cells were processed for FACS
and immunofluorescence as defined elsewhere [9].
Supplemental Data
Supplemental Data include Supplemental Experimental Procedures
(construction of plasmids; antibody sources) and 21 figures and can be
found with this article online at http://www.cell.com/current-biology/
supplemental/S0960-9822(09)01698-4.
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